BioAge Labs (BIOA) Amortization of Deferred Charges (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Amortization of Deferred Charges data on file, last reported at $16000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortization of Deferred Charges fell 86.32% year-over-year to $16000.0; the trailing twelve-month figure through Mar 2026 stood at $62000.0 (down 77.12% YoY), and the FY2025 full-year result was $163000.0, down 84.17% from the prior year.
• Amortization of Deferred Charges improved to $16000.0 in Q1 2026, from $7000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $1.9 million in Q4 2023 to a low of $7000.0 in Q4 2025.
• A 4-year average of $314800.0 and a median of $47500.0 in 2024 frame the typical range for Amortization of Deferred Charges.
• Across the five-year window, Amortization of Deferred Charges tumbled 97.78% in 2024 and plunged 61.02% in 2025, its largest moves.
• Tracing BIOA's Amortization of Deferred Charges over 4 years: stood at $1.9 million in 2023, then plunged by 97.78% to $43000.0 in 2024, then sank by 83.72% to $7000.0 in 2025, then soared by 128.57% to $16000.0 in 2026.
• Business Quant data shows BIOA's Amortization of Deferred Charges at $16000.0 in Q1 2026, $7000.0 in Q4 2025, and $16000.0 in Q3 2025.